Aligos Therapeutics annual total assets
2019
2020
2021
2022
2023
2024
2025
Aligos Therapeutics Total Assets Growth & History (ALGS)
Aligos Therapeutics's total assets was $88.5M for fiscal 2025.
View full Aligos Therapeutics company overviewAligos Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $88.5M | $18.4M | +26.31% |
| 2024 | 2024-12-31 | $70.1M | −$81.4M | −53.74% |
| 2023 | 2023-12-31 | $151.5M | $4.8M | +3.30% |
| 2022 | 2022-12-31 | $146.7M | −$88.7M | −37.68% |
| 2021 | 2021-12-31 | $235.4M | −$29.9M | −11.28% |
| 2020 | 2020-12-31 | $265.3M | $118.8M | +81.07% |
| 2019 | 2019-12-31 | $146.5M | — | — |
Aligos Therapeutics quarterly total assets
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $66.3M | −$68.4M | −50.76% |
| Q1 2026 | 2026-03-31 | $64.6M | −$86.1M | −57.16% |
| Q4 2025 | 2025-12-31 | $88.5M | $18.4M | +26.31% |
| Q3 2025 | 2025-09-30 | $109.8M | $21.3M | +24.13% |
| Q2 2025 | 2025-06-30 | $134.7M | $25.9M | +23.80% |
| Q1 2025 | 2025-03-31 | $150.7M | $22.8M | +17.82% |
| Q4 2024 | 2024-12-31 | $70.1M | −$81.4M | −53.74% |
| Q3 2024 | 2024-09-30 | $88.4M | $2.6M | +3.00% |
| Q2 2024 | 2024-06-30 | $108.8M | $2.7M | +2.53% |
| Q1 2024 | 2024-03-31 | $127.9M | $6.2M | +5.06% |
| Q4 2023 | 2023-12-31 | $151.5M | $4.8M | +3.30% |
| Q3 2023 | 2023-09-30 | $85.9M | −$78.2M | −47.67% |
| Q2 2023 | 2023-06-30 | $106.1M | −$76.4M | −41.85% |
| Q1 2023 | 2023-03-31 | $121.7M | −$88.7M | −42.16% |
| Q4 2022 | 2022-12-31 | $146.7M | −$88.7M | −37.68% |
| Q3 2022 | 2022-09-30 | $164.1M | −$99.0M | −37.63% |
| Q2 2022 | 2022-06-30 | $182.5M | −$29.4M | −13.85% |
| Q1 2022 | 2022-03-31 | $210.5M | −$24.1M | −10.26% |
| Q4 2021 | 2021-12-31 | $235.4M | −$29.9M | −11.28% |
| Q3 2021 | 2021-09-30 | $263.1M | $170.9M | +185.38% |
| Q2 2021 | 2021-06-30 | $211.9M | — | — |
| Q1 2021 | 2021-03-31 | $234.5M | — | — |
| Q4 2020 | 2020-12-31 | $265.3M | $118.8M | +81.07% |
| Q3 2020 | 2020-09-30 | $92.2M | — | — |
| Q4 2019 | 2019-12-31 | $146.5M | — | — |
Aligos Therapeutics total assets trends
Over the last five fiscal years, Aligos Therapeutics's total assets decreased from $265.3M to $88.5M, a change of −$176.8M. The latest reported quarter, Q2 2026, shows $66.3M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aligos Therapeutics source filings ↗